Prescription for Product Safety

With 80 percent of the active pharmaceutical ingredients in U.S. drugs originating from outside the country, the risk of a tainted supply chain is higher than ever—and the results can be deadly. Counterfeit and adulterated drugs are a rising problem, and although the FDA is working to better regulate the supply chain, the threat is real.

In an article published in APICS magazine, IPM’s Reg Montague discusses this growing problem and how the pharmaceutical industry is joining forces to address it.